Litcius/Paper detail

Aducanumab: First Approval

Sohita Dhillon

2021Drugs283 citationsDOI

Topics & Concepts

MedicineDementiaTolerabilityDiseaseClinical trialAlzheimer's diseaseIntensive care medicinePediatricsAdverse effectInternal medicineAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesMedicinal Plants and Neuroprotection
Aducanumab: First Approval | Litcius